1
0
0
(1 - 15 von 19
)
Drug Delivery in Oncology, 3 Volume Set: From Basic Research ...google.de
books.google.de
... Klaus Mross and Felix Kratz 1.1 Introduction: The Era of Cancer Chemotherapy The first effective anticancer drug that was developed was not worked out theo ...
Drugs Affecting Growth of Tumours - Google Books
books.google.de
During recent years the field of effective anticancer agents has substantially increased. The use of chemotherapy has been accepted as a standard therapy for...
The Cancer Chronicles: Unlocking Medicine's Deepest Mystery - George...
books.google.com.ua
A New York Times Notable Book of When the woman he loved was diagnosed with a metastatic cancer, George Johnson set out to learn everything he could about...
The Cancer Chronicles: Unlocking Medicine's Deepest Mysterybooks.google.com › books
books.google.de
... sickening side effects: “Cisplatin,” American Cancer Society website, last revised January 14, Doxorubicin has its own curious tale: Klaus Mross, ...
Peer Review reports - BMC Cancerbmccancer.biomedcentral.com › articles › peer-review
bmccancer.biomedcentral.com
Original Submission. 2 Oct 2013, Submitted, Original manuscript. 23 Oct 2013, Author responded, Author comments - Klaus Mross. Resubmission - Version 2.
Vascular effects, efficacy and safety of nintedanib in patients with ...bmccancer.biomedcentral.com › articles
bmccancer.biomedcentral.com
· Klaus Mross,; Martin Büchert,; Annette Frost,; Michael Medinger,; Peter Stopfer ...
Referee Acknowledgement for | British Journal of Cancer
www.nature.com
Referee Acknowledgement for 2012
GMS | 27. Deutscher Krebskongress | Dosing of anticancer drugs: …
www.bing.com
Web26 Mar · Klaus Mross - Klinik für Tumorbiologie, Freiburg, Deutschland 27. Deutscher Krebskongress. Berlin, Düsseldorf, Köln: German Medical Science; …
New drug that targets metastasing breast cancer in clinical phase …
www.gesundheitsindustrie-bw.de
· Dr. Klaus Mross, head of Clinical Trials at the Tumour Biology Centre in Freiburg (Photo: B. Riess/Tumour Biology Centre) “The drug targets precisely defined structures of …
Part I Principles of Tumor Targeting - Wiley-VCH
www.bing.com
WebKlaus Mross and Felix Kratz 1.1 Introduction: The Era of Cancer Chemotherapy The first effective anticancer drug that was developed was not worked out theo-retically in a …
27. Deutscher Krebskongress | Dosing of anticancer drugs: flat ...
www.egms.de
Klaus Mross - Klinik für Tumorbiologie, Freiburg, Deutschland Deutscher Krebskongress. Berlin, Düsseldorf, Köln: German Medical Science ... › dkk2006
GMS | 27th German Cancer Congress Berlin | Clinical phase I...
www.egms.de
... Tumor Biology Center; Brigritte Häring - Tumor Biology Center; Felix Kratz - Tumor Biology Center; Klaus Mross - Tumor Biology Center. 27.
Inter-relationships of paclitaxel disposition, infusion duration and...
moh-it.pure.elsevier.com
... paclitaxel disposition, infusion duration and Cremophor EL kinetics in cancer patients. Lia Van Zuylen, Luca Gianni, Jaap Verweij, Klaus Mross, Eric Brouwer, ...
More articles from Clinical studies - Anticancer Research
ar.iiarjournals.org
STEPHAN MIELKE, ALEX SPARREBOOM, DIRK BEHRINGER and KLAUS MROSS ; HANS-BERND PRISACK, CHRISTIAAN KARREMAN, OLGA MODLICH, WERNER AUDRETSCH, MAHMOUD DANAE, MAHADI ... JOACHIM DREVS, MICHAEL MEDINGER, KLAUS MROSS, STEFAN FUXIUS, JUERGEN HENNIG, MARTIN BUECHERT, ANNE THOMAS, CLEMENS UNGER, BEE-LIAN CHEN, DAVID LEBWOHL and ... › section › content
Vascular effects, efficacy and safety of nintedanib in patients ...
europepmc.org
von K Mross · · Zitiert von: 28 — Vascular effects, efficacy and safety of nintedanib in patients with advanced, refractory colorectal cancer: a prospective phase I subanalysis. Klaus Mross. › pmc
Alle Infos zum Namen "Klaus Mross"
sortiert nach Relevanz / Datum